[Alpha 1-antitrypsin as a tumor marker].
In this work we intended: a) to confirm the correlation between the increase of serum levels of alpha 1-antitrypsin (ATT) and neoplastic disease; b) to verify in what tumoural diseases the increase of ATT has a specific significance. Therefore we have examined 164 patients: 60 represented the control group and 104 were suffering from neoplastic diseases. We have subdivided the nest group according to histological type and tumour location. The result of this work has demonstrated that the increase of ATT is really determined by the existence of neoplastic disease, more than histological type or location of cancer. The AAT represents a diagnostic index of neoplastic diseases, highly sensitive but little specific.
D002277:Carcinoma / Q000097:blood; D006801:Humans; D007938:Leukemia / Q000097:blood; D008113:Liver Neoplasms / Q000097:blood; D008175:Lung Neoplasms / Q000097:blood; D008223:Lymphoma / Q000097:blood; D009369:Neoplasms / Q000097:blood*; D010641:Phenotype; D000515:alpha 1-Antitrypsin / Q000032:analysis*
D000515:alpha 1-Antitrypsin
L'alfa1-antitripsina come marker tumorale.